FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093584166> ?p ?o ?g. }

• W2093584166 endingPage "2282" @default.
• W2093584166 startingPage "2275" @default.
• W2093584166 abstract "Erythropoietin (EPO) not only stimulates erythropoiesis but also thrombopoiesis. As pegylated-interferon-alpha(PEG-IFN-alpha)-induced thrombocytopenia may become a limiting factor for continuation of therapy, the present study investigated if EPO can alleviate PEG-IFN-alpha induced thrombocytopenia. Further, we hypothesize that EPO increases platelet reactivity and protease activated receptor 1 (PAR-1) expression during combination antiviral therapy.Forty patients with chronic hepatitis C received either 10,000 IU EPO 3 x/week or placebo in a randomized, placebo-controlled, double-blinded fashion for 4 wk and combination antiviral therapy with PEG-IFN-2a and ribavirin.EPO alleviated the decrease in hemoglobin during combination antiviral therapy with ribavirin (10%vs 20%, p < 0.0001). Platelet counts decreased stronger in EPO than in placebo group on day 28 (p= 0.007). EPO induced a 40% increase in PAR-1 (p < 0.0001), which was accompanied by 100% increase in platelet reactivity (p < 0.0001). PFA-100 platelet plug formation time and PEG-IFN-alpha-induced vWF-increase were not different between study groups.Treatment with EPO alleviated the decrease in hemoglobin but worsened PEG-IFN-alpha induced thrombocytopenia after the first 4 wk of combination therapy. EPO caused PAR-1 receptor upregulation on platelets, which promoted an increase in platelet reactivity without affecting PFA-100 platelet plug formation time. EPO is not a useful option for short-term support of platelet production during antiviral therapy." @default.
• W2093584166 created "2016-06-24" @default.
• W2093584166 creator A5004045605 @default.
• W2093584166 creator A5036486301 @default.
• W2093584166 creator A5038776186 @default.
• W2093584166 creator A5073197069 @default.
• W2093584166 creator A5073880705 @default.
• W2093584166 creator A5074942131 @default.
• W2093584166 creator A5080941679 @default.
• W2093584166 creator A5086311843 @default.
• W2093584166 date "2006-10-01" @default.
• W2093584166 modified "2023-10-15" @default.
• W2093584166 title "Erythropoietin Treatment Is Associated with More Severe Thrombocytopenia in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy" @default.
• W2093584166 cites W170849090 @default.
• W2093584166 cites W189385581 @default.
• W2093584166 cites W1934976864 @default.
• W2093584166 cites W1971195332 @default.
• W2093584166 cites W1972987136 @default.
• W2093584166 cites W1975620628 @default.
• W2093584166 cites W1976784383 @default.
• W2093584166 cites W1994680327 @default.
• W2093584166 cites W2016730958 @default.
• W2093584166 cites W2031464849 @default.
• W2093584166 cites W2059950477 @default.
• W2093584166 cites W2075655319 @default.
• W2093584166 cites W2078328626 @default.
• W2093584166 cites W2081753893 @default.
• W2093584166 cites W2082036505 @default.
• W2093584166 cites W2085484838 @default.
• W2093584166 cites W2088150811 @default.
• W2093584166 cites W2091112630 @default.
• W2093584166 cites W2096437824 @default.
• W2093584166 cites W2102865648 @default.
• W2093584166 cites W2106603985 @default.
• W2093584166 cites W2114728839 @default.
• W2093584166 cites W2116514288 @default.
• W2093584166 cites W2127685726 @default.
• W2093584166 cites W2141986974 @default.
• W2093584166 cites W233692421 @default.
• W2093584166 cites W2408408662 @default.
• W2093584166 cites W2412219670 @default.
• W2093584166 cites W4238913708 @default.
• W2093584166 cites W4244312606 @default.
• W2093584166 cites W4297812089 @default.
• W2093584166 doi "https://doi.org/10.1111/j.1572-0241.2006.00774.x" @default.
• W2093584166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17032193" @default.
• W2093584166 hasPublicationYear "2006" @default.
• W2093584166 type Work @default.
• W2093584166 sameAs 2093584166 @default.
• W2093584166 citedByCount "10" @default.
• W2093584166 countsByYear W20935841662012 @default.
• W2093584166 countsByYear W20935841662014 @default.
• W2093584166 crossrefType "journal-article" @default.
• W2093584166 hasAuthorship W2093584166A5004045605 @default.
• W2093584166 hasAuthorship W2093584166A5036486301 @default.
• W2093584166 hasAuthorship W2093584166A5038776186 @default.
• W2093584166 hasAuthorship W2093584166A5073197069 @default.
• W2093584166 hasAuthorship W2093584166A5073880705 @default.
• W2093584166 hasAuthorship W2093584166A5074942131 @default.
• W2093584166 hasAuthorship W2093584166A5080941679 @default.
• W2093584166 hasAuthorship W2093584166A5086311843 @default.
• W2093584166 hasConcept C126322002 @default.
• W2093584166 hasConcept C142724271 @default.
• W2093584166 hasConcept C203014093 @default.
• W2093584166 hasConcept C204787440 @default.
• W2093584166 hasConcept C2522874641 @default.
• W2093584166 hasConcept C27081682 @default.
• W2093584166 hasConcept C2776178377 @default.
• W2093584166 hasConcept C2776408679 @default.
• W2093584166 hasConcept C2776999253 @default.
• W2093584166 hasConcept C2778534260 @default.
• W2093584166 hasConcept C2780040827 @default.
• W2093584166 hasConcept C2909179924 @default.
• W2093584166 hasConcept C71924100 @default.
• W2093584166 hasConcept C89560881 @default.
• W2093584166 hasConcept C90924648 @default.
• W2093584166 hasConcept C98274493 @default.
• W2093584166 hasConceptScore W2093584166C126322002 @default.
• W2093584166 hasConceptScore W2093584166C142724271 @default.
• W2093584166 hasConceptScore W2093584166C203014093 @default.
• W2093584166 hasConceptScore W2093584166C204787440 @default.
• W2093584166 hasConceptScore W2093584166C2522874641 @default.
• W2093584166 hasConceptScore W2093584166C27081682 @default.
• W2093584166 hasConceptScore W2093584166C2776178377 @default.
• W2093584166 hasConceptScore W2093584166C2776408679 @default.
• W2093584166 hasConceptScore W2093584166C2776999253 @default.
• W2093584166 hasConceptScore W2093584166C2778534260 @default.
• W2093584166 hasConceptScore W2093584166C2780040827 @default.
• W2093584166 hasConceptScore W2093584166C2909179924 @default.
• W2093584166 hasConceptScore W2093584166C71924100 @default.
• W2093584166 hasConceptScore W2093584166C89560881 @default.
• W2093584166 hasConceptScore W2093584166C90924648 @default.
• W2093584166 hasConceptScore W2093584166C98274493 @default.
• W2093584166 hasIssue "10" @default.
• W2093584166 hasLocation W20935841661 @default.
• W2093584166 hasLocation W20935841662 @default.
• W2093584166 hasOpenAccess W2093584166 @default.
• W2093584166 hasPrimaryLocation W20935841661 @default.

• next